Trace Biosciences

Trace Biosciences

生物技术研究

Portland,Oregon 889 位关注者

Trace Biosciences is working to eliminate surgical nerve damage using an imaging agent for enhance nerve identification

关于我们

Trace Biosciences is creating imaging agents for surgery. Our mission is to revolutionize surgery by highlighting detailed anatomy in real-time. Our first product is a nerve targeting imaging agent that will prevent surgical nerve damage. Nerve injury is a feared surgical complication affecting 25 million patients annually and incurring undue pain, loss of function, and high cost for follow on treatment and pain management. Currently, surgeons are entirely unassisted in nerve identification and preservation, relying solely on naked eye visualization or anatomical knowledge. If we can successfully develop this, our imaging agents will be used in almost all operating theaters, enable true precision surgery, and vastly improve patient outcomes. We are well funded through non-dilutive grants (SBIR, STTR + regional government) as well as venture capital investments. Founded in 2019 we are now developing our first products that will enter clinical trials in 2023.

网站
trace-bio.com
所属行业
生物技术研究
规模
2-10 人
总部
Portland,Oregon
类型
私人持股
创立
2019

地点

  • 主要

    4640 S Macadam Ave

    US,Oregon,Portland,97201

    获取路线

Trace Biosciences员工

动态

相似主页

查看职位